nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—breast cancer	0.553	1	CbGaD
Carteolol—CYP2D6—Idarubicin—breast cancer	0.061	0.414	CbGbCtD
Carteolol—CYP2D6—Vinorelbine—breast cancer	0.0298	0.202	CbGbCtD
Carteolol—CYP2D6—Tamoxifen—breast cancer	0.0269	0.183	CbGbCtD
Carteolol—CYP2D6—Vinblastine—breast cancer	0.0184	0.125	CbGbCtD
Carteolol—CYP2D6—Doxorubicin—breast cancer	0.0113	0.0766	CbGbCtD
Carteolol—Conjunctivitis—Mitoxantrone—breast cancer	0.000604	0.00243	CcSEcCtD
Carteolol—Asthenia—Letrozole—breast cancer	0.000589	0.00237	CcSEcCtD
Carteolol—Asthenia—Anastrozole—breast cancer	0.000589	0.00237	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—breast cancer	0.000588	0.00236	CcSEcCtD
Carteolol—Sinusitis—Mitoxantrone—breast cancer	0.000583	0.00234	CcSEcCtD
Carteolol—Palpitations—Goserelin—breast cancer	0.000581	0.00233	CcSEcCtD
Carteolol—Headache—Exemestane—breast cancer	0.000579	0.00233	CcSEcCtD
Carteolol—Conjunctivitis—Fluorouracil—breast cancer	0.000579	0.00232	CcSEcCtD
Carteolol—Arrhythmia—Thiotepa—breast cancer	0.000577	0.00232	CcSEcCtD
Carteolol—Dizziness—Ixabepilone—breast cancer	0.000577	0.00232	CcSEcCtD
Carteolol—Hypersensitivity—Idarubicin—breast cancer	0.000574	0.00231	CcSEcCtD
Carteolol—Bradycardia—Mitoxantrone—breast cancer	0.000568	0.00228	CcSEcCtD
Carteolol—Bradycardia—Irinotecan—breast cancer	0.000568	0.00228	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—breast cancer	0.000564	0.00226	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—breast cancer	0.000562	0.00226	CcSEcCtD
Carteolol—Oedema—Tamoxifen—breast cancer	0.000562	0.00226	CcSEcCtD
Carteolol—Sinusitis—Fluorouracil—breast cancer	0.000559	0.00224	CcSEcCtD
Carteolol—Cerebrovascular accident—Capecitabine—breast cancer	0.000551	0.00221	CcSEcCtD
Carteolol—Oedema—Melphalan—breast cancer	0.00055	0.00221	CcSEcCtD
Carteolol—Nausea—Exemestane—breast cancer	0.000549	0.00221	CcSEcCtD
Carteolol—Headache—Ixabepilone—breast cancer	0.000546	0.00219	CcSEcCtD
Carteolol—Dizziness—Letrozole—breast cancer	0.000543	0.00218	CcSEcCtD
Carteolol—Dizziness—Anastrozole—breast cancer	0.000543	0.00218	CcSEcCtD
Carteolol—Diplopia—Capecitabine—breast cancer	0.00054	0.00217	CcSEcCtD
Carteolol—Visual impairment—Irinotecan—breast cancer	0.000538	0.00216	CcSEcCtD
Carteolol—Oedema—Goserelin—breast cancer	0.000537	0.00216	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—breast cancer	0.000534	0.00215	CcSEcCtD
Carteolol—Vision blurred—Thiotepa—breast cancer	0.00053	0.00213	CcSEcCtD
Carteolol—Shock—Goserelin—breast cancer	0.000528	0.00212	CcSEcCtD
Carteolol—Palpitations—Vinorelbine—breast cancer	0.000521	0.00209	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—breast cancer	0.00052	0.00209	CcSEcCtD
Carteolol—Nausea—Ixabepilone—breast cancer	0.000518	0.00208	CcSEcCtD
Carteolol—Dizziness—Raloxifene—breast cancer	0.000515	0.00207	CcSEcCtD
Carteolol—Headache—Anastrozole—breast cancer	0.000514	0.00207	CcSEcCtD
Carteolol—Headache—Letrozole—breast cancer	0.000514	0.00207	CcSEcCtD
Carteolol—Hypotension—Melphalan—breast cancer	0.000514	0.00207	CcSEcCtD
Carteolol—Insomnia—Tamoxifen—breast cancer	0.000508	0.00204	CcSEcCtD
Carteolol—Depression—Paclitaxel—breast cancer	0.000506	0.00203	CcSEcCtD
Carteolol—Hypotension—Goserelin—breast cancer	0.000502	0.00201	CcSEcCtD
Carteolol—Dyspnoea—Tamoxifen—breast cancer	0.000501	0.00201	CcSEcCtD
Carteolol—Arrhythmia—Mitoxantrone—breast cancer	0.000499	0.002	CcSEcCtD
Carteolol—Arrhythmia—Irinotecan—breast cancer	0.000499	0.002	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—breast cancer	0.000494	0.00199	CcSEcCtD
Carteolol—Conjunctivitis—Paclitaxel—breast cancer	0.000493	0.00198	CcSEcCtD
Carteolol—Dyspnoea—Melphalan—breast cancer	0.000491	0.00197	CcSEcCtD
Carteolol—Headache—Idarubicin—breast cancer	0.000488	0.00196	CcSEcCtD
Carteolol—Headache—Raloxifene—breast cancer	0.000488	0.00196	CcSEcCtD
Carteolol—Nausea—Letrozole—breast cancer	0.000488	0.00196	CcSEcCtD
Carteolol—Nausea—Anastrozole—breast cancer	0.000488	0.00196	CcSEcCtD
Carteolol—Arrhythmia—Gemcitabine—breast cancer	0.000486	0.00195	CcSEcCtD
Carteolol—Insomnia—Goserelin—breast cancer	0.000485	0.00195	CcSEcCtD
Carteolol—Dyspnoea—Goserelin—breast cancer	0.000479	0.00192	CcSEcCtD
Carteolol—Arrhythmia—Fluorouracil—breast cancer	0.000477	0.00192	CcSEcCtD
Carteolol—Dysgeusia—Mitoxantrone—breast cancer	0.000476	0.00191	CcSEcCtD
Carteolol—Sinusitis—Paclitaxel—breast cancer	0.000476	0.00191	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—breast cancer	0.000474	0.0019	CcSEcCtD
Carteolol—Hypersensitivity—Chlorambucil—breast cancer	0.000465	0.00187	CcSEcCtD
Carteolol—Bradycardia—Paclitaxel—breast cancer	0.000463	0.00186	CcSEcCtD
Carteolol—Nausea—Raloxifene—breast cancer	0.000463	0.00186	CcSEcCtD
Carteolol—Nausea—Idarubicin—breast cancer	0.000463	0.00186	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—breast cancer	0.000462	0.00186	CcSEcCtD
Carteolol—Bronchospasm—Capecitabine—breast cancer	0.000459	0.00184	CcSEcCtD
Carteolol—Vision blurred—Mitoxantrone—breast cancer	0.000458	0.00184	CcSEcCtD
Carteolol—Asthenia—Chlorambucil—breast cancer	0.000453	0.00182	CcSEcCtD
Carteolol—Hypotension—Vinorelbine—breast cancer	0.000449	0.0018	CcSEcCtD
Carteolol—Visual impairment—Paclitaxel—breast cancer	0.000439	0.00176	CcSEcCtD
Carteolol—Vision blurred—Fluorouracil—breast cancer	0.000438	0.00176	CcSEcCtD
Carteolol—Syncope—Irinotecan—breast cancer	0.000436	0.00175	CcSEcCtD
Carteolol—Salbutamol—CYP3A4—breast cancer	0.000434	0.223	CrCbGaD
Carteolol—Diabetes mellitus—Epirubicin—breast cancer	0.000432	0.00174	CcSEcCtD
Carteolol—Dyspnoea—Vinorelbine—breast cancer	0.000429	0.00172	CcSEcCtD
Carteolol—Loss of consciousness—Irinotecan—breast cancer	0.000427	0.00172	CcSEcCtD
Carteolol—Hypersensitivity—Vinblastine—breast cancer	0.000426	0.00171	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—breast cancer	0.000424	0.0017	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—breast cancer	0.000418	0.00168	CcSEcCtD
Carteolol—Asthenia—Vinblastine—breast cancer	0.000415	0.00167	CcSEcCtD
Carteolol—Depression—Capecitabine—breast cancer	0.000415	0.00167	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—breast cancer	0.000415	0.00167	CcSEcCtD
Carteolol—Hypersensitivity—Tamoxifen—breast cancer	0.000414	0.00166	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—breast cancer	0.00041	0.00165	CcSEcCtD
Carteolol—Arrhythmia—Paclitaxel—breast cancer	0.000407	0.00163	CcSEcCtD
Carteolol—Hypersensitivity—Melphalan—breast cancer	0.000405	0.00163	CcSEcCtD
Carteolol—Conjunctivitis—Capecitabine—breast cancer	0.000404	0.00162	CcSEcCtD
Carteolol—Asthenia—Tamoxifen—breast cancer	0.000403	0.00162	CcSEcCtD
Carteolol—Nadolol—ABCB1—breast cancer	0.000403	0.207	CrCbGaD
Carteolol—Diabetes mellitus—Doxorubicin—breast cancer	0.0004	0.00161	CcSEcCtD
Carteolol—Oedema—Irinotecan—breast cancer	0.000396	0.00159	CcSEcCtD
Carteolol—Oedema—Mitoxantrone—breast cancer	0.000396	0.00159	CcSEcCtD
Carteolol—Hypersensitivity—Goserelin—breast cancer	0.000395	0.00159	CcSEcCtD
Carteolol—Asthenia—Melphalan—breast cancer	0.000395	0.00159	CcSEcCtD
Carteolol—Shock—Mitoxantrone—breast cancer	0.00039	0.00157	CcSEcCtD
Carteolol—Shock—Irinotecan—breast cancer	0.00039	0.00157	CcSEcCtD
Carteolol—Dysgeusia—Paclitaxel—breast cancer	0.000388	0.00156	CcSEcCtD
Carteolol—Oedema—Gemcitabine—breast cancer	0.000386	0.00155	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—breast cancer	0.000385	0.00155	CcSEcCtD
Carteolol—Asthenia—Goserelin—breast cancer	0.000385	0.00155	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—breast cancer	0.000384	0.00154	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—breast cancer	0.000384	0.00154	CcSEcCtD
Carteolol—Dizziness—Vinblastine—breast cancer	0.000383	0.00154	CcSEcCtD
Carteolol—Bradycardia—Capecitabine—breast cancer	0.00038	0.00153	CcSEcCtD
Carteolol—Oedema—Fluorouracil—breast cancer	0.00038	0.00153	CcSEcCtD
Carteolol—Diplopia—Epirubicin—breast cancer	0.000376	0.00151	CcSEcCtD
Carteolol—Nausea—Chlorambucil—breast cancer	0.000375	0.00151	CcSEcCtD
Carteolol—Vision blurred—Paclitaxel—breast cancer	0.000373	0.0015	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—breast cancer	0.000372	0.00149	CcSEcCtD
Carteolol—Dizziness—Tamoxifen—breast cancer	0.000372	0.00149	CcSEcCtD
Carteolol—Hypotension—Mitoxantrone—breast cancer	0.00037	0.00149	CcSEcCtD
Carteolol—Hypotension—Irinotecan—breast cancer	0.00037	0.00149	CcSEcCtD
Carteolol—Headache—Vinblastine—breast cancer	0.000362	0.00146	CcSEcCtD
Carteolol—Hypotension—Gemcitabine—breast cancer	0.000361	0.00145	CcSEcCtD
Carteolol—Visual impairment—Capecitabine—breast cancer	0.00036	0.00145	CcSEcCtD
Carteolol—Insomnia—Irinotecan—breast cancer	0.000359	0.00144	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—breast cancer	0.000357	0.00143	CcSEcCtD
Carteolol—Syncope—Paclitaxel—breast cancer	0.000355	0.00143	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—breast cancer	0.000355	0.00143	CcSEcCtD
Carteolol—Dizziness—Goserelin—breast cancer	0.000355	0.00143	CcSEcCtD
Carteolol—Pindolol—CYP2D6—breast cancer	0.000355	0.182	CrCbGaD
Carteolol—Hypotension—Fluorouracil—breast cancer	0.000355	0.00143	CcSEcCtD
Carteolol—Hypersensitivity—Vinorelbine—breast cancer	0.000354	0.00142	CcSEcCtD
Carteolol—Dyspnoea—Mitoxantrone—breast cancer	0.000353	0.00142	CcSEcCtD
Carteolol—Dyspnoea—Irinotecan—breast cancer	0.000353	0.00142	CcSEcCtD
Carteolol—Headache—Tamoxifen—breast cancer	0.000352	0.00141	CcSEcCtD
Carteolol—Palpitations—Paclitaxel—breast cancer	0.00035	0.00141	CcSEcCtD
Carteolol—Insomnia—Gemcitabine—breast cancer	0.000349	0.0014	CcSEcCtD
Carteolol—Loss of consciousness—Paclitaxel—breast cancer	0.000348	0.0014	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—breast cancer	0.000348	0.0014	CcSEcCtD
Carteolol—Asthenia—Vinorelbine—breast cancer	0.000345	0.00139	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—breast cancer	0.000345	0.00138	CcSEcCtD
Carteolol—Dyspnoea—Gemcitabine—breast cancer	0.000344	0.00138	CcSEcCtD
Carteolol—Nausea—Vinblastine—breast cancer	0.000344	0.00138	CcSEcCtD
Carteolol—Insomnia—Fluorouracil—breast cancer	0.000343	0.00138	CcSEcCtD
Carteolol—Dyspnoea—Fluorouracil—breast cancer	0.000339	0.00136	CcSEcCtD
Carteolol—Hypersensitivity—Thiotepa—breast cancer	0.000338	0.00136	CcSEcCtD
Carteolol—Headache—Goserelin—breast cancer	0.000336	0.00135	CcSEcCtD
Carteolol—Nausea—Tamoxifen—breast cancer	0.000334	0.00134	CcSEcCtD
Carteolol—Arrhythmia—Capecitabine—breast cancer	0.000334	0.00134	CcSEcCtD
Carteolol—Asthenia—Thiotepa—breast cancer	0.000329	0.00132	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—breast cancer	0.000329	0.00132	CcSEcCtD
Carteolol—Nausea—Melphalan—breast cancer	0.000327	0.00131	CcSEcCtD
Carteolol—Oedema—Paclitaxel—breast cancer	0.000323	0.0013	CcSEcCtD
Carteolol—Nausea—Goserelin—breast cancer	0.000319	0.00128	CcSEcCtD
Carteolol—Dysgeusia—Capecitabine—breast cancer	0.000318	0.00128	CcSEcCtD
Carteolol—Shock—Paclitaxel—breast cancer	0.000318	0.00128	CcSEcCtD
Carteolol—Dizziness—Vinorelbine—breast cancer	0.000318	0.00128	CcSEcCtD
Carteolol—Depression—Methotrexate—breast cancer	0.000309	0.00124	CcSEcCtD
Carteolol—Vision blurred—Capecitabine—breast cancer	0.000306	0.00123	CcSEcCtD
Carteolol—Dizziness—Thiotepa—breast cancer	0.000304	0.00122	CcSEcCtD
Carteolol—Hypotension—Paclitaxel—breast cancer	0.000302	0.00121	CcSEcCtD
Carteolol—Headache—Vinorelbine—breast cancer	0.000301	0.00121	CcSEcCtD
Carteolol—Syncope—Docetaxel—breast cancer	0.000301	0.00121	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—breast cancer	0.000301	0.00121	CcSEcCtD
Carteolol—Palpitations—Docetaxel—breast cancer	0.000297	0.00119	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—breast cancer	0.000295	0.00119	CcSEcCtD
Carteolol—Insomnia—Paclitaxel—breast cancer	0.000292	0.00117	CcSEcCtD
Carteolol—Hypersensitivity—Mitoxantrone—breast cancer	0.000292	0.00117	CcSEcCtD
Carteolol—Hypersensitivity—Irinotecan—breast cancer	0.000292	0.00117	CcSEcCtD
Carteolol—Syncope—Capecitabine—breast cancer	0.000292	0.00117	CcSEcCtD
Carteolol—Dyspnoea—Paclitaxel—breast cancer	0.000288	0.00116	CcSEcCtD
Carteolol—Headache—Thiotepa—breast cancer	0.000288	0.00116	CcSEcCtD
Carteolol—Palpitations—Capecitabine—breast cancer	0.000287	0.00115	CcSEcCtD
Carteolol—Loss of consciousness—Capecitabine—breast cancer	0.000286	0.00115	CcSEcCtD
Carteolol—Nausea—Vinorelbine—breast cancer	0.000286	0.00115	CcSEcCtD
Carteolol—Asthenia—Mitoxantrone—breast cancer	0.000284	0.00114	CcSEcCtD
Carteolol—Asthenia—Irinotecan—breast cancer	0.000284	0.00114	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—breast cancer	0.000282	0.00113	CcSEcCtD
Carteolol—Hypersensitivity—Fluorouracil—breast cancer	0.00028	0.00112	CcSEcCtD
Carteolol—Asthenia—Gemcitabine—breast cancer	0.000277	0.00111	CcSEcCtD
Carteolol—Oedema—Docetaxel—breast cancer	0.000274	0.0011	CcSEcCtD
Carteolol—Nausea—Thiotepa—breast cancer	0.000273	0.0011	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—breast cancer	0.000272	0.00109	CcSEcCtD
Carteolol—Shock—Docetaxel—breast cancer	0.00027	0.00108	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—breast cancer	0.000268	0.00108	CcSEcCtD
Carteolol—Oedema—Capecitabine—breast cancer	0.000265	0.00107	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—breast cancer	0.000265	0.00106	CcSEcCtD
Carteolol—Dizziness—Irinotecan—breast cancer	0.000262	0.00105	CcSEcCtD
Carteolol—Shock—Capecitabine—breast cancer	0.000261	0.00105	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—breast cancer	0.000261	0.00105	CcSEcCtD
Carteolol—Propranolol—CYP1A1—breast cancer	0.00026	0.133	CrCbGaD
Carteolol—Hypotension—Docetaxel—breast cancer	0.000256	0.00103	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—breast cancer	0.000252	0.00101	CcSEcCtD
Carteolol—Dizziness—Fluorouracil—breast cancer	0.000251	0.00101	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—breast cancer	0.000251	0.00101	CcSEcCtD
Carteolol—Headache—Mitoxantrone—breast cancer	0.000248	0.000998	CcSEcCtD
Carteolol—Headache—Irinotecan—breast cancer	0.000248	0.000998	CcSEcCtD
Carteolol—Hypotension—Capecitabine—breast cancer	0.000248	0.000996	CcSEcCtD
Carteolol—Insomnia—Docetaxel—breast cancer	0.000248	0.000996	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—breast cancer	0.000245	0.000985	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—breast cancer	0.000244	0.000981	CcSEcCtD
Carteolol—Headache—Gemcitabine—breast cancer	0.000242	0.000972	CcSEcCtD
Carteolol—Insomnia—Capecitabine—breast cancer	0.00024	0.000964	CcSEcCtD
Carteolol—Hypersensitivity—Paclitaxel—breast cancer	0.000238	0.000957	CcSEcCtD
Carteolol—Headache—Fluorouracil—breast cancer	0.000238	0.000956	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—breast cancer	0.000237	0.000952	CcSEcCtD
Carteolol—Dyspnoea—Capecitabine—breast cancer	0.000237	0.00095	CcSEcCtD
Carteolol—Nausea—Mitoxantrone—breast cancer	0.000235	0.000946	CcSEcCtD
Carteolol—Nausea—Irinotecan—breast cancer	0.000235	0.000946	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—breast cancer	0.000232	0.000934	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—breast cancer	0.000232	0.000932	CcSEcCtD
Carteolol—Asthenia—Paclitaxel—breast cancer	0.000232	0.000932	CcSEcCtD
Carteolol—Nausea—Gemcitabine—breast cancer	0.000229	0.000921	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—breast cancer	0.000228	0.000916	CcSEcCtD
Carteolol—Nausea—Fluorouracil—breast cancer	0.000226	0.000906	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—breast cancer	0.000222	0.000891	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—breast cancer	0.000215	0.000864	CcSEcCtD
Carteolol—Dizziness—Paclitaxel—breast cancer	0.000214	0.000859	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—breast cancer	0.000213	0.000857	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—breast cancer	0.000205	0.000824	CcSEcCtD
Carteolol—Syncope—Epirubicin—breast cancer	0.000203	0.000816	CcSEcCtD
Carteolol—Headache—Paclitaxel—breast cancer	0.000203	0.000814	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—breast cancer	0.000202	0.000811	CcSEcCtD
Carteolol—Palpitations—Epirubicin—breast cancer	0.0002	0.000804	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—breast cancer	0.000199	0.0008	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—breast cancer	0.000198	0.000793	CcSEcCtD
Carteolol—Asthenia—Docetaxel—breast cancer	0.000197	0.00079	CcSEcCtD
Carteolol—Hypersensitivity—Capecitabine—breast cancer	0.000195	0.000785	CcSEcCtD
Carteolol—Propranolol—CYP2D6—breast cancer	0.000194	0.0993	CrCbGaD
Carteolol—Nausea—Paclitaxel—breast cancer	0.000192	0.000771	CcSEcCtD
Carteolol—Asthenia—Capecitabine—breast cancer	0.00019	0.000765	CcSEcCtD
Carteolol—Syncope—Doxorubicin—breast cancer	0.000188	0.000755	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—breast cancer	0.000185	0.000744	CcSEcCtD
Carteolol—Oedema—Epirubicin—breast cancer	0.000185	0.000743	CcSEcCtD
Carteolol—Hypotension—Methotrexate—breast cancer	0.000185	0.000741	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—breast cancer	0.000184	0.00074	CcSEcCtD
Carteolol—Shock—Epirubicin—breast cancer	0.000182	0.000731	CcSEcCtD
Carteolol—Dizziness—Docetaxel—breast cancer	0.000181	0.000728	CcSEcCtD
Carteolol—Insomnia—Methotrexate—breast cancer	0.000179	0.000718	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—breast cancer	0.000176	0.000707	CcSEcCtD
Carteolol—Dizziness—Capecitabine—breast cancer	0.000175	0.000705	CcSEcCtD
Carteolol—Hypotension—Epirubicin—breast cancer	0.000173	0.000694	CcSEcCtD
Carteolol—Headache—Docetaxel—breast cancer	0.000172	0.00069	CcSEcCtD
Carteolol—Oedema—Doxorubicin—breast cancer	0.000171	0.000687	CcSEcCtD
Carteolol—Shock—Doxorubicin—breast cancer	0.000168	0.000676	CcSEcCtD
Carteolol—Insomnia—Epirubicin—breast cancer	0.000167	0.000672	CcSEcCtD
Carteolol—Headache—Capecitabine—breast cancer	0.000166	0.000668	CcSEcCtD
Carteolol—Propranolol—CYP3A4—breast cancer	0.000166	0.0851	CrCbGaD
Carteolol—Dyspnoea—Epirubicin—breast cancer	0.000165	0.000662	CcSEcCtD
Carteolol—Nausea—Docetaxel—breast cancer	0.000163	0.000654	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—breast cancer	0.00016	0.000642	CcSEcCtD
Carteolol—Nausea—Capecitabine—breast cancer	0.000158	0.000633	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—breast cancer	0.000155	0.000621	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—breast cancer	0.000152	0.000613	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—breast cancer	0.000146	0.000585	CcSEcCtD
Carteolol—Asthenia—Methotrexate—breast cancer	0.000142	0.000569	CcSEcCtD
Carteolol—Propranolol—ABCB1—breast cancer	0.000138	0.0709	CrCbGaD
Carteolol—Hypersensitivity—Epirubicin—breast cancer	0.000136	0.000547	CcSEcCtD
Carteolol—Asthenia—Epirubicin—breast cancer	0.000133	0.000533	CcSEcCtD
Carteolol—Dizziness—Methotrexate—breast cancer	0.000131	0.000525	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—breast cancer	0.000126	0.000506	CcSEcCtD
Carteolol—Headache—Methotrexate—breast cancer	0.000124	0.000497	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—breast cancer	0.000123	0.000493	CcSEcCtD
Carteolol—Dizziness—Epirubicin—breast cancer	0.000122	0.000491	CcSEcCtD
Carteolol—Nausea—Methotrexate—breast cancer	0.000117	0.000471	CcSEcCtD
Carteolol—Headache—Epirubicin—breast cancer	0.000116	0.000465	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—breast cancer	0.000113	0.000454	CcSEcCtD
Carteolol—Nausea—Epirubicin—breast cancer	0.00011	0.000441	CcSEcCtD
Carteolol—Headache—Doxorubicin—breast cancer	0.000107	0.00043	CcSEcCtD
Carteolol—Nausea—Doxorubicin—breast cancer	0.000102	0.000408	CcSEcCtD
Carteolol—CYP2D6—Metabolism—GSTA2—breast cancer	1.78e-05	0.000361	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.77e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.76e-05	0.000357	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX4—breast cancer	1.76e-05	0.000357	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SULT1A1—breast cancer	1.76e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	1.75e-05	0.000356	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	1.75e-05	0.000356	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	1.74e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.72e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.72e-05	0.000348	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA1—breast cancer	1.72e-05	0.000348	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—IDH1—breast cancer	1.72e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRL—breast cancer	1.71e-05	0.000346	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR1—breast cancer	1.71e-05	0.000346	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.7e-05	0.000346	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NAT2—breast cancer	1.7e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STK11—breast cancer	1.68e-05	0.000341	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADAM10—breast cancer	1.68e-05	0.000341	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRL—breast cancer	1.67e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR1—breast cancer	1.67e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLG—breast cancer	1.66e-05	0.000338	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADAM10—breast cancer	1.65e-05	0.000334	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STK11—breast cancer	1.65e-05	0.000334	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT2—breast cancer	1.64e-05	0.000334	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF10—breast cancer	1.64e-05	0.000332	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLG—breast cancer	1.63e-05	0.00033	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT2—breast cancer	1.61e-05	0.000327	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF10—breast cancer	1.6e-05	0.000325	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	1.58e-05	0.000321	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFA—breast cancer	1.58e-05	0.00032	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	1.56e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	1.55e-05	0.000314	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFA—breast cancer	1.54e-05	0.000314	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ITPR1—breast cancer	1.53e-05	0.000311	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	1.52e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP3—breast cancer	1.52e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB4—breast cancer	1.52e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT5A—breast cancer	1.52e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	1.52e-05	0.000308	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ITPR1—breast cancer	1.5e-05	0.000304	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT5A—breast cancer	1.49e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB4—breast cancer	1.49e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP3—breast cancer	1.49e-05	0.000302	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DPYD—breast cancer	1.49e-05	0.000302	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MED12—breast cancer	1.49e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	1.48e-05	0.000301	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SMAD4—breast cancer	1.47e-05	0.000299	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDOA—breast cancer	1.46e-05	0.000297	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1R—breast cancer	1.46e-05	0.000297	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	1.46e-05	0.000296	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SMAD4—breast cancer	1.44e-05	0.000293	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HES1—breast cancer	1.44e-05	0.000292	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1R—breast cancer	1.43e-05	0.000291	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NCOR1—breast cancer	1.43e-05	0.00029	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	1.43e-05	0.00029	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	1.43e-05	0.000289	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA3—breast cancer	1.42e-05	0.000289	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CSF2—breast cancer	1.41e-05	0.000287	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF1—breast cancer	1.41e-05	0.000287	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A2—breast cancer	1.41e-05	0.000287	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RAF1—breast cancer	1.41e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HES1—breast cancer	1.41e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRG1—breast cancer	1.4e-05	0.000285	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NCOR1—breast cancer	1.4e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	1.4e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—H2AFX—breast cancer	1.39e-05	0.000283	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IL2—breast cancer	1.39e-05	0.000283	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—E2F1—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CSF2—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF1—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CPT1A—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTR—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG2—breast cancer	1.38e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RAF1—breast cancer	1.38e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	1.38e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRG1—breast cancer	1.37e-05	0.000279	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—H2AFX—breast cancer	1.36e-05	0.000277	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IL2—breast cancer	1.36e-05	0.000277	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HPGDS—breast cancer	1.36e-05	0.000275	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—E2F1—breast cancer	1.35e-05	0.000275	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HBA1—breast cancer	1.35e-05	0.000274	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	1.35e-05	0.000274	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SPP1—breast cancer	1.33e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	1.32e-05	0.000269	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACHE—breast cancer	1.32e-05	0.000267	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTT1—breast cancer	1.32e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	1.31e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	1.31e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SPP1—breast cancer	1.3e-05	0.000264	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	1.29e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	1.29e-05	0.000261	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	1.28e-05	0.000261	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL2—breast cancer	1.26e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TERT—breast cancer	1.26e-05	0.000256	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP17A1—breast cancer	1.25e-05	0.000253	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL2—breast cancer	1.24e-05	0.000251	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TERT—breast cancer	1.23e-05	0.00025	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS1—breast cancer	1.23e-05	0.00025	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO1—breast cancer	1.23e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	1.22e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	1.21e-05	0.000245	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	1.2e-05	0.000243	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA2—breast cancer	1.19e-05	0.000241	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	1.18e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—breast cancer	1.18e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CAV1—breast cancer	1.17e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—breast cancer	1.15e-05	0.000234	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—breast cancer	1.15e-05	0.000234	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FASN—breast cancer	1.15e-05	0.000234	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BCHE—breast cancer	1.15e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CAV1—breast cancer	1.14e-05	0.000232	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC5A5—breast cancer	1.13e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—breast cancer	1.13e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—breast cancer	1.12e-05	0.000228	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FN1—breast cancer	1.11e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—breast cancer	1.1e-05	0.000223	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	1.1e-05	0.000223	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A1—breast cancer	1.09e-05	0.000222	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NQO1—breast cancer	1.09e-05	0.000222	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	1.09e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FN1—breast cancer	1.09e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	1.07e-05	0.000218	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP3A4—breast cancer	1.07e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	1.06e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KIT—breast cancer	1.06e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APC—breast cancer	1.06e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	1.06e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGF—breast cancer	1.05e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1B1—breast cancer	1.05e-05	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APC—breast cancer	1.04e-05	0.000211	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.04e-05	0.000211	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KIT—breast cancer	1.04e-05	0.000211	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.03e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGF—breast cancer	1.03e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	1.02e-05	0.000206	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA1—breast cancer	1e-05	0.000203	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BRAF—breast cancer	9.98e-06	0.000203	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	9.95e-06	0.000202	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STK11—breast cancer	9.85e-06	0.0002	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP19A1—breast cancer	9.85e-06	0.0002	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BRAF—breast cancer	9.76e-06	0.000198	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—breast cancer	9.72e-06	0.000197	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT2—breast cancer	9.72e-06	0.000197	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	9.67e-06	0.000196	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—breast cancer	9.51e-06	0.000193	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT2—breast cancer	9.5e-06	0.000193	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	9.46e-06	0.000192	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	9.33e-06	0.00019	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	9.25e-06	0.000188	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	9.23e-06	0.000187	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—COMT—breast cancer	9.16e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	9.14e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	9.13e-06	0.000185	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—breast cancer	9.12e-06	0.000185	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	9.04e-06	0.000184	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	9.03e-06	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—breast cancer	8.99e-06	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ITPR1—breast cancer	8.97e-06	0.000182	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	8.94e-06	0.000181	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—breast cancer	8.81e-06	0.000179	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—breast cancer	8.63e-06	0.000175	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—breast cancer	8.62e-06	0.000175	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMS—breast cancer	8.48e-06	0.000172	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	8.4e-06	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G4A—breast cancer	8.38e-06	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOR1—breast cancer	8.38e-06	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—breast cancer	8.38e-06	0.00017	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MDM2—breast cancer	8.36e-06	0.00017	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RAF1—breast cancer	8.33e-06	0.000169	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RELA—breast cancer	8.3e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	8.25e-06	0.000167	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	8.21e-06	0.000167	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MDM2—breast cancer	8.18e-06	0.000166	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RAF1—breast cancer	8.15e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTOR—breast cancer	8.14e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	8.14e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RELA—breast cancer	8.12e-06	0.000165	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	8.07e-06	0.000164	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—breast cancer	8.02e-06	0.000163	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	7.96e-06	0.000162	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTOR—breast cancer	7.96e-06	0.000162	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1A1—breast cancer	7.94e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ERCC2—breast cancer	7.88e-06	0.00016	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	7.82e-06	0.000159	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	7.77e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	7.65e-06	0.000155	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	7.64e-06	0.000155	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	7.6e-06	0.000154	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	7.55e-06	0.000153	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—breast cancer	7.48e-06	0.000152	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL2—breast cancer	7.47e-06	0.000152	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	7.47e-06	0.000152	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—breast cancer	7.44e-06	0.000151	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—breast cancer	7.4e-06	0.00015	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	7.39e-06	0.00015	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—breast cancer	7.32e-06	0.000149	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL2—breast cancer	7.31e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—breast cancer	7.28e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—breast cancer	7.27e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUN—breast cancer	7.27e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	7.21e-06	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—breast cancer	7.13e-06	0.000145	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUN—breast cancer	7.11e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—breast cancer	7.07e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	7.06e-06	0.000143	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	7.05e-06	0.000143	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTEN—breast cancer	7.03e-06	0.000143	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—breast cancer	6.92e-06	0.00014	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	6.89e-06	0.00014	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	6.88e-06	0.00014	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTEN—breast cancer	6.88e-06	0.00014	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	6.86e-06	0.000139	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAV1—breast cancer	6.83e-06	0.000139	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	6.73e-06	0.000137	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	6.71e-06	0.000136	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—breast cancer	6.52e-06	0.000132	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—breast cancer	6.38e-06	0.000129	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	6.35e-06	0.000129	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—breast cancer	6.29e-06	0.000128	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—breast cancer	6.22e-06	0.000126	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	6.21e-06	0.000126	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—breast cancer	6.15e-06	0.000125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	6.01e-06	0.000122	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	5.88e-06	0.000119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—breast cancer	5.84e-06	0.000119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	5.83e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—breast cancer	5.72e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—breast cancer	5.72e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	5.7e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—breast cancer	5.59e-06	0.000113	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—breast cancer	5.47e-06	0.000111	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—breast cancer	5.4e-06	0.00011	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—breast cancer	5.4e-06	0.00011	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—breast cancer	5.28e-06	0.000107	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—breast cancer	5.16e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	4.96e-06	0.000101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	4.85e-06	9.85e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—breast cancer	4.8e-06	9.74e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—breast cancer	4.77e-06	9.68e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—breast cancer	4.72e-06	9.59e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—breast cancer	4.69e-06	9.53e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—breast cancer	4.59e-06	9.32e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—breast cancer	4.49e-06	9.11e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—breast cancer	4.39e-06	8.92e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—breast cancer	4.3e-06	8.72e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTEN—breast cancer	4.12e-06	8.36e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—breast cancer	4.05e-06	8.23e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—breast cancer	3.96e-06	8.05e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—breast cancer	2.91e-06	5.9e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—breast cancer	2.37e-06	4.82e-05	CbGpPWpGaD
